CT
Coldstart Tx
This company focuses on developing novel therapeutic modalities for challenging biological targets. They utilize proprietary screening platforms to identify and advance small molecule drug candidates. The core mission is to translate innovative science into treatments for unmet medical needs.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cold Start Therapeutics focuses on developing novel small molecule therapeutics for challenging protein-protein interactions. The company utilizes proprietary screening platforms to identify compounds that modulate historically undruggable targets. This approach aims to create new treatment options for diseases with high unmet medical need.